ADAM17 and cancer: Given that ADAM17 is depleted in the cancer cell population, we speculated that the cancer cells are the source of HB-EGF, and we confirmed that reexpression of ADAM17 in Adam17–/– 4T1 cells rescued the secretion of HB-EGF (Figure 4C).